title: [Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients].
authors.forename: M G
authors.initials: MG
authors.lastname: Bernengo
authors.forename: G C
authors.initials: GC
authors.lastname: Doveil
authors.forename: A
authors.initials: A
authors.lastname: Appino
authors.forename: M R
authors.initials: MR
authors.lastname: Sertoli
authors.forename: A
authors.initials: A
authors.lastname: Ardizzoni
authors.forename: M G
authors.initials: MG
authors.lastname: Vidili
mesh_terms: D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007370:Interferon Type I / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008545:Melanoma / Q000628:therapy*; D011994:Recombinant Proteins; D012074:Remission Induction; D012878:Skin Neoplasms / Q000628:therapy*
chemical_list: D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
vernacular_title: Ruolo dell'interferon alfa-2 nel melanoma. Risultati di uno studio in fase II su 27 pazienti.